SCHEMBL29754281

SCHEMBL29754281

O=C1CCc2ccc(F)cc2N1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 1/20 0.62
KMT2A Q03164 2/20 0.58
KDM4E B2RXH2 1/20 0.58
LMNA P02545 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
SRD5A1 P18405 2/20 0.57
NPC1 O15118 2/20 0.55
MAPK13 O15264 1/20 0.55
MAPK12 P53778 1/20 0.55
MAPK11 Q15759 1/20 0.55
MAPK14 Q16539 1/20 0.55
TRPV1 Q8NER1 1/20 0.50
PKM P14618 2/20 0.48
MAOB P27338 5/20 0.48
MAOA P21397 4/20 0.48
CRBN Q96SW2 1/20 0.48
MAPT P10636 1/20 0.47
HTR5A P47898 2/20 0.46
KIF11 P52732 1/20 0.45
AOC3 Q16853 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4102521 1.00 CA9 (0.62) CA9KMT2AKDM4ELMNASMN1; SMN2
SCHEMBL7505614 0.91 MAPT (0.59) CA9KMT2AKDM4ELMNASMN1; SMN2
SCHEMBL2233596 0.85 PKM (0.58) CA9KMT2AKDM4ELMNASMN1; SMN2
SCHEMBL260027 0.82 AHR (0.61) KMT2AKDM4ELMNASMN1; SMN2SRD5A1
SCHEMBL30648196 0.82 AHR (0.61) KMT2AKDM4ELMNASMN1; SMN2SRD5A1
SCHEMBL7717893 0.81 AHR (0.59) KMT2AKDM4ELMNASMN1; SMN2SRD5A1
SCHEMBL3308993 0.80 CA9 (0.53) CA9KMT2AKDM4ELMNASMN1; SMN2
SCHEMBL31310681 0.78 MAPT (0.58) KMT2ASRD5A1NPC1MAPK13MAPK12
SCHEMBL8031052 0.78 HTR5A (0.44) CA9KMT2AKDM4ELMNASMN1; SMN2
SCHEMBL31310679 0.78 MAPT (0.58) KMT2ASRD5A1NPC1MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638881-B Tetrahydroquinoline derivatives for the treatment of metastatic and chemotherapy-resistant cancers 普林斯顿大学托管委员会 2025-01-07 CN disclosed
CN-114436955-B Tetrahydroquinoline and benzomorpholine derivatives or salts thereof, and preparation method and application thereof 复旦大学 2024-08-09 CN disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed
CN-115362003-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2022-11-18 CN disclosed
CN-114436955-A Tetrahydroquinoline and benzomorpholine derivatives or salts thereof, and preparation method and application thereof 复旦大学 2022-05-06 CN disclosed